MonTa Biosciences
PrivateLast Round
Early Funding
Oct 20, 2022
Total Funding Raised
$16.99M
Company Overview
MonTa Biosciences is a biotechnology company that develops cancer immunotherapies using micelle-based nanoparticle technology to stimulate immune responses against tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MonTa Biosciences Comparables
Compare MonTa Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seven and Eight Biopharmaceuticals Inc. | 83% | |
| Ascendis Pharma A/S | 74% | |
| Nektar Therapeutics | 71% | |
MonTa Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 20, 2022 | ||||
| Series A | Jan 9, 2020 | ||||
| Accelerator | Mar 10, 2017 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors grew 385% MoM, reaching 1.4K.
- Mar 1, 2026
Monthly visitors increased 179% MoM.
MonTa Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MonTa Biosciences's valuation, stock price, and market status.